Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-N-((6S,15S,18S,21S,24S,27S,30S,36S,39S,42S,45S)-27-((1H-imidazol-5-yl)methyl)-1-amino-6-(2-amino-2-oxoethylcarbamoyl)-42-benzyl-15,24-bis(3-guanidinopropyl)-39-(hydroxymethyl)-1-imino-21-isobutyl-30-isopropyl-18,36-dimethyl-8,11,14,17,20,23,26,29,32,35,38,41,44-tridecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazahexatetracontan-45-yl)-2-(2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)acetamido)-5-guanidinopentanamide
ID: ALA4786844
Chembl Id: CHEMBL4786844
PubChem CID: 162666876
Max Phase: Preclinical
Molecular Formula: C83H132N34O19
Molecular Weight: 1910.19
Molecule Type: Unknown
Associated Items: